Table 2.
Baseline characteristics of participants in each study
| Study | Any DR |
Severe DR |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case subjects |
Control subjects |
Case subjects |
Control subjects |
|||||||||
| Age, years | Sex, % male | Sample size | Age, years | Sex, % male | Sample size | Age, years | Sex, % male | Sample size | Age, years | Sex, % male | Sample size | |
| AAPDR |
59.4 |
40.9 |
274 |
61.5 |
32.1 |
56 |
59.5 |
41.2 |
255 |
61.5 |
32.1 |
56 |
| AGES Reykjavik |
76.2 |
52.9 |
85 |
76.0 |
56.3 |
222 |
– |
– |
||||
| AUST |
66.4 |
58.6 |
522 |
67.3 |
52.4 |
435 |
64.6 |
60.8 |
187 |
67.3 |
52.4 |
435 |
| BMES |
64.3 |
50.0 |
124 |
63.8 |
48.1 |
208 |
– |
– |
||||
| CHS-AA |
77.0 |
9.1 |
22 |
78.3 |
46.2 |
39 |
– |
– |
||||
| CHS-Whites |
78.1 |
46.4 |
28 |
77.4 |
43.4 |
143 |
– |
– |
||||
| Genetic Center, China Medical University Hospital, Taiwan |
62.0 |
50.3 |
177 |
58.0 |
53.9 |
579 |
62.2 |
50.0 |
78 |
58.0 |
53.9 |
579 |
| GOLDR |
53.4 |
40.4 |
292 |
54.0 |
32.6 |
221 |
53.6 |
47.4 |
78 |
54.0 |
32.6 |
221 |
| JHS |
61.2 |
34.1 |
91 |
63.7 |
36.2 |
160 |
64.4 |
30.8 |
12 |
63.7 |
36.2 |
160 |
| MESA-AA |
63.2 |
50.6 |
101 |
63.6 |
45.6 |
258 |
68.3 |
50.0 |
11 |
63.6 |
45.6 |
258 |
| MESA-CHN |
67.0 |
48.0 |
25 |
66.9 |
51.9 |
79 |
– |
– |
||||
| MESA-EU |
61.9 |
55.6 |
38 |
65.3 |
61.2 |
200 |
– |
– |
||||
| MESA-HIS |
66.4 |
54.6 |
88 |
64.0 |
47.5 |
179 |
– |
– |
||||
| SCES |
62.0 |
57.7 |
71 |
62.5 |
57.7 |
168 |
61.6 |
75.0 |
12 |
62.5 |
57.7 |
168 |
| SiMES |
63.2 |
41.9 |
198 |
62.9 |
47.7 |
363 |
63.1 |
35.1 |
37 |
62.9 |
47.7 |
363 |
| SINDI |
61.8 |
55.9 |
304 |
60.9 |
51.8 |
537 |
62.4 |
46.9 |
49 |
60.9 |
51.8 |
537 |
| Starr County Health Studies |
60.3 |
40.6 |
529 |
57.8 |
40.2 |
249 |
62.0 |
47.6 |
124 |
59.0 |
39.1 |
654 |
| TUDR | – | – | 61.2 | 44.2 | 434 | 66.8 | 58.3 | 549 | ||||